The Altissimo Study for Wet AMD

The Altissimo Study for Wet AMD

You may want to consider the ALTISSIMO clinical research study for people who have Neovascular age-r

12/12/2019

If your loved one has Wet AMD, you may want to consider the ALTISSIMO clinical research study.
Visit our website to learn more: www.altissimostudy.com

The Altissimo Study | Neovascular AMD | See If You Qualify The Altissimo clinical research study is evaluating an investigational drug that could potentially be administered to AMD patients as an injection. Learn more.

The Altissimo Study for Wet AMD

Neovascular age-related macular degeneration, also called wet AMD, is a leading cause of vision loss in those over 50 years of age. Wet AMD significantly impacts reading, driving, watching television, and performing other everyday tasks.

Mission

The ALTISSIMO clinical research study is evaluating an investigational drug that could potentially be administered to AMD patients as a way to treat wet AMD and decrease the burden of frequent injections into the eye. The study will compare this investigational product to a current standard of care treatment injected every 2 months.

Safety Information